🇺🇸 FDA
Patent

US 7511038

Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

granted A61PA61P1/04A61P11/00

Quick answer

US patent 7511038 (Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors) held by Laboratories Almirall, S.A. expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Laboratories Almirall, S.A.
Grant date
Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P1/04, A61P11/00, A61P11/06, A61P17/00